This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at IndiaMART InterMESH Limited's (NSE:INDIAMART) P/E ratio and reflect on what it ...

IndiaMART InterMESH Ltd. disclosed the outcome of a meeting with Marval Capital Ltd, conducted via video conference, as per regulatory requirements. The meeting did not involve any sharing of ...

The drugmaker's India legal team held discussions with IndiaMART's top executives to develop a "framework" for regularly alerting the online marketplace about listings by counterfeiters in an effort ...

The micro, small, and medium enterprises (MSMEs) in India have increasingly incorporated technology into their businesses, with the majority now considered digitally savvy. They have implemented ...

https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/indiamart-intermesh-buyback-why-you-are-better-off-tendering-your-shares ...

Indiamart Intermesh Q4 Results Live : Indiamart Intermesh declared their Q4 results on 30 Apr, 2024, with the topline increasing by 17.1% and the profit by 78.04% YoY. In comparison to the previous ...

Novo Nordisk is the sole patent holder of semaglutide, the active ingredient in both Wegovy and Novo's diabetes drug Ozempic, which are not yet approved for sale in India. A spokesman for Novo India ...

HYDERABAD, India (Reuters) - Indian online marketplace IndiaMART has been removing unauthorized listings of Novo Nordisk (CSE:NOVOb)'s blockbuster weight-loss drug Wegovy after holding talks with the ...